Reports Suggest Some Indian Cricketers Are Using Weight-Loss Injections for Lean Physique
Unverified reports indicate that several Indian cricketers, including Indian Premier League (IPL) players and younger athletes, are using prescription weight-loss injections to achieve a leaner appearance. According to the reports, which cite unnamed sources, these medications are being viewed by some as a shortcut to reduce weight in combination with their normal workout routines.
What Happened
According to claims reported by CricBlogger and shared by CricTracker, certain Indian cricketers have been experimenting with prescription weight-management medications without having a clinical requirement. The reports attribute this trend to an increased emphasis on maintaining a lean physique within modern Indian cricket, where fitness standards have been heavily influenced by benchmarks set by players like Virat Kohli.
It is important to emphasize that no specific player names have been identified, the report has not been independently verified, and neither the Board of Control for Cricket in India (BCCI) nor the IPL management has issued any official statement on the matter.
Key Highlights
- Reports citing unnamed sources claim Indian cricketers and IPL players are taking prescription weight-loss drugs for cosmetic slimming.
- The trend reportedly includes younger players using the medication without a diagnosed clinical need.
- No official verification, named player confirmations, or statements have been released by the BCCI or the IPL.
- GLP-1 medications, such as semaglutide and tirzepatide, are primarily engineered for type-2 diabetes and clinical obesity management.
- Medical experts caution against using these treatments for cosmetic purposes due to potential side effects like nausea, vomiting, diarrhoea, constipation, and abdominal bloating.
- Increased accessibility and generic alternatives in the Indian market have made these prescription treatments more widely available.
Why This Matters
Glucagon-like peptide-1 (GLP-1) is a naturally occurring gut hormone released after meals to stimulate insulin production, slow stomach emptying, and signal satiety to the brain. Pharmaceutical formulations, such as Mounjaro (tirzepatide) and Wegovy (semaglutide), are designed specifically to treat chronic conditions like type-2 diabetes and clinically defined obesity under medical supervision.
Health professionals have stressed that taking such drugs strictly for aesthetic goals carries notable health risks. Possible adverse effects range from gastrointestinal distress, including nausea, diarrhoea, and bloating, to more severe complications. The growing availability of these medications at varying price points in India has raised concerns regarding their non-clinical use among athletes striving to meet demanding physical aesthetics.
What to Watch Next
As the report relies entirely on anonymous claims, any formal response, advisory, or policy clarification regarding prescription medication guidelines from the BCCI, IPL governing bodies, or team medical staff remains to be seen.
Frequently Asked Questions
What are GLP-1 weight-loss medications?
GLP-1 medications are pharmaceutical drugs that mimic the natural gut hormone glucagon-like peptide-1. They work by stimulating insulin release, slowing digestion, and reducing appetite to assist with glycemic control and clinical weight management.
Have any cricketers been named or officially sanctioned?
No. The reports rely entirely on unnamed sources, contain no confirmed player names, and have not been corroborated by official statements from the BCCI or IPL.
What are the known side effects of these injections?
Common side effects associated with GLP-1 treatments include nausea, vomiting, constipation, diarrhoea, abdominal discomfort, and bloating, alongside the possibility of more serious medical complications.
Source: CricTracker via CricBlogger